Jamese Bradner News Today

Amgen's potential weight loss drug is heading to a larger phase 3 trial

CCCC | Complete C4 Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Rating) and Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, earnings, risk and institutional ownership. Volatility & Risk Calliditas Therapeutics AB (publ) […]

StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) in a research report report published on Thursday. The firm issued a hold rating on the stock. Several other research firms have also weighed in on SYRS. JMP Securities reduced their price objective on shares of Syros Pharmaceuticals from $16.00 to $15.00 in […]

StockNews.com initiated coverage on shares of Syros Pharmaceuticals (NASDAQ:SYRS – Get Rating) in a report published on Thursday. The brokerage issued a hold rating on the stock. A number of other equities analysts have also recently weighed in on the stock. JMP Securities reduced their price target on shares of Syros Pharmaceuticals from $16.00 to […]

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) has received a consensus recommendation of “Moderate Buy” from the five brokerages that are covering the company, MarketBeat reports. One research analyst has rated the stock with a hold rating and three have issued a buy rating on the company. The average 1-year target price among brokerages that […]

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 649,500 shares, an increase of 21.6% from the February 28th total of 534,300 shares. Based on an average trading volume of 131,800 shares, the days-to-cover ratio is […]

Should You Buy or Sell Syros Pharmaceuticals Stock? Get The Latest SYRS Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) has earned an average recommendation of “Moderate Buy” from the six analysts that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1 year target price among […]

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS – Get Rating) has received an average recommendation of “Moderate Buy” from the six research firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average twelve-month price objective among […]